MoneyWorks4Me

Orchid Pharma informs about disclosure

16 Jun 2021 Evaluate
Orchid Pharma has informed about disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Approval for Reclassification of Shareholders of Orchid Pharma ('the Company') from the 'Promoter and Promoter Group' category to 'Public' category under Regulation 31A of the SEBI (LODR) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1847.95
Dr. Reddys Labs. 1149.30
Cipla 1360.50
Lupin 2046.50
Zydus Lifesciences 1108.45
View more..